Phase II study of AGS-16C3F vs Axitinib in Metastatic Renal Cell Carcinoma

Clinical Trial Grant

Duke Scholars

Principal Investigator Tian Zhang Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Astellas Pharma Global Development, Inc

Start Date

November 15, 2016

End Date

November 14, 2021

Administered By

Duke Cancer Institute

Awarded By

Astellas Pharma Global Development, Inc

Start Date

November 15, 2016

End Date

November 14, 2021